Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288574 · ClinicalTrials.gov registry record · Phase 4
Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
A Phase 4 study of Anorexia Nervosa and Eating Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT00288574 is a Phase 4 study of Anorexia Nervosa and Eating Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 93 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00288574, a Phase 4 study of Anorexia Nervosa and Eating Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of fluoxetine versus placebo in reducing the rate of relapse of anorexia nervosa (AN) and enhancing the psychosocial and behavioral recovery of people who have been treated for AN.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Fluoxetine
Study Locations (1)
New York
- New York State Psychiatric Institute/Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2000-01 |
| Est. Completion | 2005-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00288574
The ClinicalTrials.gov registry entry for NCT00288574 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (90% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00288574 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00288574 about?
NCT00288574 is a clinical study titled "Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa". This study will evaluate the effectiveness of fluoxetine versus placebo in reducing the rate of relapse of anorexia nervosa (AN) and enhancing the psychosocial and behavioral recovery of people who have been treated for AN.
What is the current status of trial NCT00288574?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 93 participants. The study started on 2000-01. Estimated completion is 2005-05.
What conditions does trial NCT00288574 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Eating Disorders.
What interventions are being tested in trial NCT00288574?
The interventions under investigation include: Placebo (DRUG), Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00288574?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00288574 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.